Lilly PACKAGE LABEL - Mounjaro Multi-Dose Vial - 15 mg/0.6 mL Dose (60 mg/2.4 mL[25 mg/mL]) Rx Only NDC 0002-4612-11 Mounjaro (tirzepatide) injection 60 mg/2.4 mL (25 mg/mL) ATTENTION: Contains 4 doses of 15 mg/0.6 mL 2.4 mL MULTI-DOSE VIAL For Subcutaneous Use Needles and Syringes are not included Dispense enclosed Medication Guide to each patient
If you are consistently getting fewer doses than calculated, switch to low-dead-space syringes and verify your reconstitution water volume with precision for the next vial
Oxidative Medicine and Cellular Longevity , 2012.PMID: 22900128 Review of GHK-Cu as an endogenous tripeptide that declines with age, with evidence for antioxidant, anti-inflammatory, and tissue-remodeling properties
Is GHK-Cu therapy right for you
After 24 h medium was discarded as recommended in [9] and 110 l medium without CuCl 2 or CuSO 4 containing 10 l CCK-8 Solution was added
Predrag Sikiric, Sven Seiwerth, Zeljko Grabarevic, Petek, M., Rucman, R., Turkovic, B., Ivo Rotkvic, Vjekoslav Jagic, Duvnjak, M., Mise, S., Sanja Djacic, Jadranka Separovic, Marija Veljaca, Ahmet Sallmani, Banic, M., & Brkic, T